BridgeMD
New treatment option for Laparoscopic Myomectomy
Official title Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping
ClinicalTrials.gov ID: NCT07200778
What this study is testing
- What it's testing
- the purpose of this study is to examine how Umbilico-uterine trunk occlusion reduces surgery-associated blood loss in Laparoscopic Myomectomy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 45, women only
You may be able to join if
- Age between 19 and 45
- Symptoms of menorrhagia, pelvic pain, or infertility
- Plan to have a laparoscopic myomectomy
- Number of myomas ≤ 4, with the largest myoma measuring ≤ 9 cm
You likely can't join if
- Postmenopausal status
- Dominant pedunculated subserosal FIGO classification (6-7)
- Submucosal type of myoma FIGO classification (0-2)
- Suspicion of malignant uterine or adnexal diseases
- Major medical comorbidities or psychiatric illnesses that could affect follow-up and/or compliance
- Refusal to participate or provide consent to the procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Minya, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minya, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.